BOT 2.17% 33.8¢ botanix pharmaceuticals ltd

Price predictions, page-58

  1. 1,728 Posts.
    lightbulb Created with Sketch. 1126
    I think we need to be mindful though that Qbrexza didn't sell in Japan previously, which is supposed to be BOT's closest competitor in the US.

    Also, Qbrexza only sold $25m in the US last FY, so it would seem that even though Ecclock did well in Japan, it does seem BOT are expecting quite a take-up of SB in the US. I'm not sure their $100m is realistic. Don't get me wrong, I would love it to be $100m turnover within a year, but I expect that is years and years down the track.

    Then again, maybe Qbrexza is an absolutely crap product in the hyperhidrosis world and we'll see SB sold at record levels.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
33.8¢
Change
-0.008(2.17%)
Mkt cap ! $606.3M
Open High Low Value Volume
35.0¢ 35.0¢ 33.0¢ $1.973M 5.853M

Buyers (Bids)

No. Vol. Price($)
9 313554 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 276653 17
View Market Depth
Last trade - 15.56pm 04/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.